News for TAPIMMUNE INC (TPIV)

News for TAPIMMUNE INC
Date Headline
Feb 06, 2018 06:30 AM TapImmune to Participate in Two Upcoming Investor Conferences
Jan 03, 2018 06:30 AM TapImmune to Present at Biotech Showcase™ 2018
Dec 19, 2017 10:35 AM How Does TapImmune Inc (NASDAQ:TPIV) Compare To The Healthcare Sector?
Dec 12, 2017 06:30 AM TapImmune Announces Enrollment of First Patient in Phase 2 Clinical Trial for Treating Triple-Negative Breast Cancer Funded by U.S. Department of Defense
Dec 11, 2017 04:05 PM TapImmune, Inc. Presentation Now Available for On-Demand Viewing
Dec 06, 2017 06:30 AM TapImmune Appoints Richard Kenney, M.D., F.A.C.P., as Acting Chief Medical Officer
Dec 04, 2017 08:35 AM Live Investor Conference & Webinar: NASDAQ, NYSE and OTC companies present December 7th
Dec 04, 2017 08:35 AM TapImmune Inc. to Webcast, Live, at VirtualInvestorConferences.com December 7
Nov 21, 2017 06:30 AM TapImmune to Present at 29th Annual Piper Jaffray Healthcare Conference
Nov 17, 2017 04:05 PM TapImmune to Present at World Vaccine & Immunotherapy Congress West Coast